Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
AIM ImmunoTech Inc. (AIM) had Consolidated Net Income/Loss of $-4.17M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$0.02M |
|
$-4.17M |
|
$0.04M |
|
$-0.02M |
|
$2.97M |
|
$-2.95M |
|
$-1.22M |
|
$-4.17M |
|
$-4.17M |
|
$-4.17M |
|
$-4.17M |
|
|
Consolidated Net Income/Loss |
$-4.17M |
$-4.17M |
|
$-2.95M |
|
$-2.17M |
|
1.62M |
|
1.62M |
|
$1.63 |
|
$1.63 |
|
| Balance Sheet Financials | |
$3.29M |
|
$0.07M |
|
$2.49M |
|
$5.78M |
|
$6.22M |
|
$0.93M |
|
$9.34M |
|
$15.56M |
|
$-9.78M |
|
$-11.44M |
|
$-9.78M |
|
3.07M |
|
| Cash Flow Statement Financials | |
$-10.96M |
|
$1.85M |
|
$10.39M |
|
$1.70M |
|
$2.98M |
|
$1.28M |
|
$0.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.53 |
|
-- |
|
-- |
|
-0.10 |
|
-0.48 |
|
-90.48% |
|
-14057.14% |
|
-14057.14% |
|
-- |
|
-19880.95% |
|
-19880.95% |
|
$-10.96M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
3.00 |
|
30.00 |
|
42.68% |
|
36.48% |
|
-72.21% |
|
47.14% |
|
$-3.19 |
|
$-6.77 |
|
$-6.77 |
|